QA: Virpax Pharmaceuticals Inc in us_pharma/2024

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001708331_2025_Virpax_Pharmaceuticals_Inc.pdf

Logs

warning The stock price does not exist industry.us_generic {}

Graph

Absolute values for 0001708331, Virpax Pharmaceuticals Inc

  xvar xval
0 AssetsCurrent 1,555,614
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 0
3 remainder_Assets 0
4 LiabilitiesCurrent 2,469,374
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 3,172,736
9 ResearchAndDevelopmentExpense 5,757,462
10 remainder_Expenses 0
11 remainder_Revenues 0
12 remainder_NetIncome 239,843
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 1,555,614
1 Liabilities 2,469,374
2 Expenses 8,930,198
3 Revenues 0
4 StockholdersEquity -913,760
5 NetIncome -8,690,355
6 ComprehensiveNetIncome -8,690,355
7 BaseVar 6,597,514
8 EconomicCapitalRatiobeforeLimitedLiability -5.31
9 EconomicCapitalRatio 0.148

Edgar->Model Mapping

Feature Distribution

Change over Time